Finance

Beta
Lists
BTAI:NASDAQ
BioXcel Therapeutics Inc
$1.40
+6.87%
(+0.090) 1D
$1.38
-1.43% (-0.020)
After hours
Closed: Jun 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BTAI...
Open
$1.30
High
$1.46
Low
$1.28
Mkt. cap
43.23M
Avg. vol.
657.31K
Volume
0.00
52-wk high
$8.08
52-wk low
$1.01
EPS
-$5.74
Beta
0.31
Shares outstanding
30.88M
No. of employees
29
Open
$1.30
High
$1.46
Low
$1.28
Mkt. cap
43.23M
Avg. vol.
657.31K
Volume
0.00
52-wk high
$8.08
52-wk low
$1.01
EPS
-$5.74
Beta
0.31
Shares outstanding
30.88M
No. of employees
29
News stories
From sources across the web
About BioXcel Therapeutics Inc
CEO-
Employees29
Founded2017
HeadquartersNew Haven, Connecticut, United States
SectorBiotechnology
Websitebioxceltherapeutics.com
Analyst ratings
Based on 1 analyst giving stock ratings to BTAI in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for BTAI in the last 3 months
Highest
Current $1.40
$5.00 (+257.14%)
Average
$5.00 (+257.14%)
Lowest
$5.00 (+257.14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$5.00
+257.1%
04/10/2026
Alec Stranahan
Bank of America Securities
Sell
Reiterated
$1.00
-28.6%
03/27/2026
Michael King
Rodman & Renshaw
Buy
Initiated
$17.00
+1,114.3%
03/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
120.00K
98.00K
256.00K
206.00K
Cost of goods sold
107.00K
11.00K
32.00K
283.00K
Cost of revenue
107.00K
11.00K
32.00K
283.00K
Research and development expenses
10.26M
8.74M
6.70M
2.96M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.61M
5.38M
3.80M
7.19M
Operating expense
15.86M
14.12M
10.51M
10.15M
Total operating expenses
15.97M
14.13M
10.54M
10.43M
Operating income
-15.85M
-14.03M
-10.28M
-10.22M
Other non operating income
657.00K
-12.55M
1.81M
1.52M
EBT including unusual items
-19.19M
-30.91M
-12.54M
-12.69M
EBT excluding unusual items
-19.19M
-30.72M
-12.54M
-12.69M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-19.19M
-30.91M
-12.54M
-12.69M
Net profit margin
-15,989.17%
-31,541.84%
-4,900.39%
-6,160.68%
Earnings per share
-2.45
-2.16
-
-0.54
Interest and investment income
230.00K
236.00K
321.00K
211.00K
Interest expense
-4.22M
-4.37M
-4.40M
-4.20M
Net interest expenses
-3.99M
-4.14M
-4.08M
-3.99M
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.78M
-13.96M
-10.21M
-10.16M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer